CD22-targeted CAR-T therapy

CD22-targeted chimeric antigen receptor T-cell

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD22-targeted CAR-T therapy, covering 2016-06-09 to 2016-06-09. Get the full timeline:

Most recent: Clinical Trial Update: CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies [Phase 1, Phase 2]